Anzeige
Mehr »
Login
Samstag, 15.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QQB6 ISIN: IT0005373789 Ticker-Symbol: 78Q 
Frankfurt
14.05.21
09:16 Uhr
14,520 Euro
+0,060
+0,41 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PHILOGEN SPA Chart 1 Jahr
5-Tage-Chart
PHILOGEN SPA 5-Tage-Chart

Aktuelle News zur PHILOGEN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PHILOGEN Aktie jetzt für 0€ handeln
MiPhilogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress250Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress May 12, 2021 NidlegyTM on track for Phase III European trial in stage IIIB/C melanoma. Opening of...
► Artikel lesen
12.04.Philogen S.p.A.: Philogen Announces Publication of Best-in-Class FAP-Targeting Small Molecule Ligand (OncoFAP) in PNAS361(i) Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs - (ii) OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer SIENA...
► Artikel lesen
12.04.Philogen S.p.A.: Philogen Announces Publication of the Construction and Application of an Innovative DNA-Encoded Chemical Library in Nature Chemistry212(i) Study shows the generation of a high-quality stereo- and regiodefined DNA-encoded chemical library - (ii) Identified ligands against tumor-associated antigens can serve as vehicles for pharmacodelivery...
► Artikel lesen
12.04.Philogen S.p.A.: Philogen Announces Participation to the 10th World Congress of Melanoma213(i) Philogen will give a poster presentation about the phase II study of Daromun (Nidlegy) for the treatment of non-melanoma skin cancer - (ii) Study shows promising early signs of efficacy in patients...
► Artikel lesen
10.03.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 10.03.2021721The following instruments on XETRA do have their first trading 10.03.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 10.03.2021 Aktien 1 CA00143Y1034 AI/ML Innovations...
► Artikel lesen
26.02.Biotech Philogen expected to be priced at 17 eur/shr, bookrunner says-
26.06.20Philogen Received Clinical Trial Authorisation With Nidlegy in Nonmelanoma Skin Cancer424SIENA, Italy, June 26, 2020 /PRNewswire/ -- Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that the Swiss national competent authority Swissmedic issued...
► Artikel lesen
24.06.20Philogen Received Combination Pack Approval for Nidlegy333SIENA, Italy, June 24, 2020 /PRNewswire/ -- Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that, on Jan. 30, 2020, EMA's CHMP expressed a favorable opinion...
► Artikel lesen
8 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1